行情

GILD

GILD

吉利德科技
NASDAQ

实时行情|Nasdaq Last Sale

72.85
-1.01
-1.37%
盘后: 73.19 +0.34 +0.47% 19:50 03/27 EDT
开盘
73.71
昨收
73.86
最高
75.39
最低
71.91
成交量
1,652.16万
成交额
--
52周最高
85.97
52周最低
60.89
市值
917.19亿
市盈率(TTM)
17.31
分时
5日
1月
3月
1年
5年

分析师评级

28位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测GILD价格均价为74.91,最高价位90.00,最低价为53.00。

EPS

GILD 新闻

更多
  • 瑞德西韦临床报告将在4月发布,疫苗猴子实验很成功!
  • 钛媒体 · 2小时前
  • RetirementRx: Amid The Meltdown
  • Seeking Alpha - Article · 7小时前
  • Developing a vaccine takes 10 years. Sanofi seeks to do so within 18 months
  • CNBC.com · 14小时前
  • Coronavirus Drugs Already in the Pipeline
  • Kiplinger · 18小时前

所属板块

生物技术和医学研究
-2.43%
制药与医学研究
-0.87%

热门股票

代码
价格
涨跌幅

GILD 简况

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.
展开

微牛提供Gilead Sciences, Inc.(NASDAQ-GILD)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的GILD股票新闻,以帮助您做出投资决策。